IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MOTTA, IRENE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.693
NA - Nord America 2.530
AS - Asia 2.031
SA - Sud America 205
AF - Africa 39
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.525
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.458
GB - Regno Unito 1.274
CN - Cina 797
IT - Italia 768
SG - Singapore 468
DE - Germania 459
SE - Svezia 420
RU - Federazione Russa 177
IN - India 173
BR - Brasile 156
IE - Irlanda 129
TR - Turchia 110
ID - Indonesia 99
FR - Francia 75
HK - Hong Kong 73
FI - Finlandia 64
DK - Danimarca 60
KR - Corea 58
CA - Canada 55
NL - Olanda 46
UA - Ucraina 40
VN - Vietnam 34
TH - Thailandia 31
IQ - Iraq 29
GR - Grecia 28
JP - Giappone 27
EU - Europa 26
AU - Australia 25
CH - Svizzera 24
AT - Austria 22
CO - Colombia 21
PL - Polonia 21
TW - Taiwan 20
BE - Belgio 19
PK - Pakistan 18
ES - Italia 17
MX - Messico 14
PH - Filippine 14
MY - Malesia 13
IR - Iran 12
PT - Portogallo 12
RO - Romania 8
UZ - Uzbekistan 8
DZ - Algeria 7
AR - Argentina 6
BD - Bangladesh 6
BG - Bulgaria 6
EE - Estonia 6
LK - Sri Lanka 6
MA - Marocco 6
PE - Perù 6
EG - Egitto 5
IL - Israele 5
KE - Kenya 5
LB - Libano 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BO - Bolivia 4
CL - Cile 4
EC - Ecuador 4
LY - Libia 4
ZA - Sudafrica 4
KG - Kirghizistan 3
LT - Lituania 3
OM - Oman 3
TN - Tunisia 3
BH - Bahrain 2
CY - Cipro 2
CZ - Repubblica Ceca 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
SC - Seychelles 2
SI - Slovenia 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
CG - Congo 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 8.550
Salva come PNG Salva come JPEG
Città #
Southend 1.177
Chandler 350
Singapore 323
Milan 286
Frankfurt am Main 191
Beijing 156
Princeton 143
Council Bluffs 125
Dublin 122
Ann Arbor 121
Ashburn 117
Seattle 106
Wilmington 94
Fairfield 91
Santa Clara 87
Jakarta 63
Dearborn 60
Woodbridge 56
Houston 54
Des Moines 53
Hong Kong 52
Nanjing 46
Bengaluru 45
Jinan 42
Istanbul 38
New York 38
Boardman 36
Toronto 36
Mountain View 34
Cambridge 33
Rome 33
Shenyang 33
Guangzhou 31
Berlin 27
Redwood City 27
Helsinki 26
Nuremberg 26
Redmond 25
Phoenix 21
Andover 20
London 20
Hebei 19
Shanghai 19
Fuzhou 18
Somerville 18
Brussels 17
Los Angeles 17
Munich 17
San Diego 17
Chicago 16
Genoa 16
Nanchang 16
Bühl 15
Changsha 15
Fremont 15
Naples 15
Bogotá 14
Sakarya 14
Duhok 13
Jiaxing 13
Tianjin 13
Hyderabad 12
Tokyo 12
Warsaw 12
Athens 11
Eitensheim 11
Grafing 11
Hangzhou 11
Jacksonville 11
Semarang 11
Silver Spring 11
São Paulo 11
Turin 11
Bangkok 10
Bitonto 10
Brasília 10
Erbil 10
Haikou 10
Lappeenranta 10
Paris 10
Seoul 10
Sunnyvale 10
Zhengzhou 10
Bologna 9
Central District 9
Islamabad 9
Kuala Lumpur 9
Manchester 9
Marseille 9
Mumbai 9
Ningbo 9
Rho 9
Sydney 9
Vienna 9
Amsterdam 8
Chiang Mai 8
Dong Ket 8
Hefei 8
Kent 8
Manila 8
Totale 5.163
Salva come PNG Salva come JPEG
Nome #
Elevated liver iron concentration is a marker of increased morbidity in patients with beta thalassemia intermedia 568
A holistic approach to iron chelation therapy in transfusion-dependent thalassemia patients with serum ferritin below 500 μg/L 258
Adrenal insufficiency: An emerging challenge in thalassemia? 239
Genetic variability of TMPRSS6 gene and its association with iron deficiency anemia 203
2'-O-methoxyethyl splice-switching oligos correct splicing from IVS2-745 β-thalassemia patient cells restoring HbA production and chain rebalance 201
La doppia eterozigosi HBS/HBC : un problema emergente 198
Anemia in Clinical Practice-Definition and Classification : does Hemoglobin Change With Aging? 161
Activin receptor-ligand trap for the treatment of β-thalassemia : a serendipitous discovery 152
Iron deficiency from the standpoint of cardiac rehabilitation : Novel therapeutic opportunities 151
Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease 151
Finding and treating gaucher disease type 1 - The role of the haematologist 144
HCC nei pazienti talassemici : l’esperienza del centro anemie congenite di Milano 143
Anemia in the elderly : evaluation in consecutive patients admitted to an Internal Medicine Unit 142
Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with beta-thalassemia intermedia 141
Prolonged PT and aPTT in a patient with severe proteinuria 138
Evaluation of liver disease in a cohort of patients affected by thalassemia intermedia 136
Anemia in elderly hospitalized patients : prevalence and clinical impact 135
Circulating cell-free DNA and ineffective erythropoiesis in nontransfusion-dependent β-thalassemia 135
Dyspnoea : focus on the chest but don’t forget the rest 131
Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP) 125
Iron metabolism in macrophages in Non trasfusion dependent Thalassemia 123
Clinical Complications and Their Management 123
Innovative Treatments for Rare Anemias 122
Development of liver fibrosis/cirrhosis in adult HCV positive thalassemia major patients 121
A multicenter Observational Study for Early Diagnosis of Gaucher Disease in patients with Splenomegaly and/or Thrombocytopenia 117
Is the heart a target organ in Gaucher disease? 116
Anemia of chronic disease : A unique defect of iron recycling for many different chronic diseases 115
Differential redox state and iron regulation in chronic obstructive pulmonary disease, acute respiratory distress syndrome and coronavirus disease 2019 115
A giant adrenal myelolipoma in a beta-thalassemia major patient : Does ineffective erythropoiesis play a role? 112
A case of relapsing fever 111
Curing hemoglobinopathies : challenges and advances of conventional and new gene therapy approaches 111
Rise of the planet of rare anemias: An update on emerging treatment strategies 108
Laboratory diagnosis of thalassemia 107
Development of liver fibrosis/cirrhosis in adult HCV positive thalassemia major patients 106
A multicentre observational study for early diagnosis of Gaucher disease in patients with splenomegaly and/or thrombocytopenia 106
Alternative Pathway Involvement in Protoporphyria Patients Related to Sun Exposure 106
Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia 106
Management of chronic patients during the COVID-19 pandemic: the experience of a referral center for rare hematological disorders in the hardest-hit region in Italy 105
Epidemiological shift of glucose-6-phosphate dehydrogenase mutations in Northern Italy in the last 15 years 105
SARS-CoV-2 infection in beta thalassemia : preliminary data from the Italian experience 104
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy : comment 99
Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease 94
Liver iron concentration and morbidity in patients with thalassemia intermedia 93
Redefining thalassemia as a hypercoagulable state 92
The anemia of elderly in the twenty-first century 91
$\upalpha$-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study [alpha-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study] 89
Loss of weight: observing the patient versus lab tests 88
Gaucher disease : clinical follow-up and management with individualized treatment 87
Treatment with ferric carboxymaltose in stable patients with severe iron deficiency anemia in the emergency department 86
Management of age-associated medical complications in patients with β-thalassemia 85
Beta thalassemia : New therapeutic options beyond transfusion and iron chelation 85
Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers 84
The autophagy-activating kinase ULK1 mediates clearance of free α-globin in β-thalassemia 83
Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity 82
Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with beta-thalassemia intermedia 79
Deciphering cytopenias in internal medicine: a single-center observational study 77
Prognostic role of transferrin saturation in heart failure patients 77
Investigational drugs in phase I and phase II clinical trials for thalassemia 76
Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature 76
Migalastat treatment in a kidney-transplanted patient with fabry disease and n215s mutation: The first case report 76
The α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study 72
Acquired Refractory Iron Deficiency Anemia 70
Advancing the care of β-thalassaemia patients with novel therapies 69
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection 69
Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations 68
Ferric carboxymaltose for sub-acute and chronic iron deficiency anemia in inherited platelet function defects 66
Reactivation of developmentally silenced globin genes by forced chromatin looping 65
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for {COVID}-19: comment 65
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study 61
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease 61
Hyperferritinemia and Diagnosis of type 1 Gaucher Disease 57
Anemia management and transfusion strategy in internal medicine units: Less is more 55
Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence 52
Iron status in chronic inflammatory disease: therapeutic implications 51
Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia 50
Splenomegaly: Dare to think rare 47
Deferasirox: an orphan drug for chronic iron overload in non-transfusion dependent thalassemia syndromes 44
Interpreting Iron Homeostasis in Congenital and Acquired Disorders 43
New therapeutic targets in transfusion-dependent and -independent thalassemia 42
Heme Biosynthetic Gene Expression Analysis With dPCR in Erythropoietic Protoporphyria Patients 39
Effect of Migalastat on cArdiac InvOlvement in FabRry DiseAse: MAIORA study 38
Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis 37
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry 37
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial 33
Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia 31
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with transfusion-dependent β-thalassemia 28
Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease 27
Decrease in Hemoglobin Levels during Acute Attacks in Patients with Idiopathic Recurrent Pericarditis: A Model of Anemia in Acute Disease 27
A glutamine metabolic switch supports erythropoiesis 26
Clinical complications and their management 24
Drug design and development for rare hematologic diseases 18
Step out of the shadows: a call for action for rare diseases 12
Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective 8
Redox Balance in β-Thalassemia and Sickle Cell Disease: A Love and Hate Relationship 6
Prolonged PT and aPTT in a patient with severe proteinuria 1
A Case of Hodgkin Lymphoma in a Gaucher Disease Patient: Distinguishing Gaucher and Pseudo-Gaucher Cells 1
Totale 9.090
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.018
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020408 0 0 0 0 0 0 0 0 163 115 51 79
2020/20211.106 61 58 64 50 100 79 64 116 138 133 158 85
2021/20221.225 95 99 84 76 113 57 74 89 149 78 88 223
2022/20231.478 170 162 137 110 164 225 25 114 172 42 120 37
2023/20241.190 42 81 82 90 275 81 80 56 42 77 125 159
2024/20251.674 111 243 80 270 213 155 191 269 142 0 0 0
Totale 9.090